Takeda Pharmaceutical Company Banner Image

Takeda Pharmaceutical Company

  • Ticker TAK
    Exchange NYSE More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Takeda Pharmaceutical Company Logo Image
  • 10,000+ Employees
  • Based in Tokyo, Japan
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and GastroenterologyMore (GI). They also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. They are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging their enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Their employees are committed to improving quality of life for patients and to working with their partners in health care in approximately 80 countries.
4.8 / 5.0 (83)

Takeda Pharmaceutical Company reports have an aggregate usefulness score of 4.8 based on 83 reviews.

Takeda Pharmaceutical Company

Most Recent Annual Report

Takeda Pharmaceutical Company
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Takeda Pharmaceutical Company Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!